Message
  • You do not have access to view this article. Please login.

New! Biostatistics in Neuromodulation Explained

The INS, in collaboration with The Newcastle Cognition Lab at the University of Newcastle, is proud to launch a new series of short articles explaining how to critically apprise clinically-relevant literature to evaluate evidence and inform practice. Each primer features a single topic and an example within the context of clinical neuromodulation research and practice.

Upon reading these articles, readers will be able to:  

  • understand statistical methods, their interpretation, and their limitations
  • identify cognitive biases to avoid inadvertently misinterpreting evidence
  • interpret data for a deeper understanding of clinical research to inform clinical practice

Articles:

Confidence Intervals: Narrowing Down the Doubt

How to Interpret a Bayes Factor

N-of-1 Trials & Their Use in Neuromodulation

Types of Data and the Appropriate Tests for Them

Receiver Operating Characteristics and the Area Under the Curve

What a P-Value Can and Cannot Tell You

The Fragility Index

How to Select and Evaluate a Sample Size


Authors:

Quentin F. Gronau, Garston Liang, and Alexander Thorpe
The Newcastle Cognition Lab
The University of Newcastle
Newcastle, NSW Australia